Thursday’s Hot List: Vodafone Group (NASDAQ:VOD), Broadcom (NASDAQ:BRCM), United Community Banks, Inc. (NASDAQ:UCBI), EXCO Resources Inc. (NYSE:XCO), Wix.com Ltd. (NASDAQ:WIX)
Vodafone Group Plc (ADR) (NASDAQ:VOD) announced its interim management statement for the first quarter ended Jun 30, 2014, on Jul 25.As the company witnessed a revenue decline, its share price went down by 22 cents and closed at $34.16 in the last trading session. Vodafone Group Plc (ADR) (NASDAQ:VOD)’s stock on 30 July traded at beginning with a price of $34.30and when day-trade ended the … Continue reading Thursday’s Hot List: Vodafone Group (NASDAQ:VOD), Broadcom (NASDAQ:BRCM), United Community Banks, Inc. (NASDAQ:UCBI), EXCO Resources Inc. (NYSE:XCO), Wix.com Ltd. (NASDAQ:WIX)
Stocks in Focus : MGM Resorts (NYSE:MGM), NPS Pharmaceuticals (NASDAQ:NPSP), LeMaitre Vascular (NASDAQ:LMAT), Range Resources (NYSE:RRC), BlackRock Maryland Municipal (NYSEMKT:BZM)
The Women’s Leadership Conference announces its 2014 program featuring two days of keynote speakers, breakout sessions, luncheons and networking opportunities. The conference, themed “Women Inspiring Women,” will be held Aug. 6 & 7 at the MGM Resorts International (NYSE:MGM) Grand Conference Center in Las Vegas. MGM Resorts International (NYSE:MGM)’s stock on 30 July traded at beginning with a price of $27.13and when day-trade ended the … Continue reading Stocks in Focus : MGM Resorts (NYSE:MGM), NPS Pharmaceuticals (NASDAQ:NPSP), LeMaitre Vascular (NASDAQ:LMAT), Range Resources (NYSE:RRC), BlackRock Maryland Municipal (NYSEMKT:BZM)
Stocks to Watch: Masco (NYSE:MAS), Intel (NASDAQ:INTC), Digirad Corporation (NASDAQ:DRAD), Kforce Inc. (NASDAQ:KFRC), Norfolk Southern Corporation (NYSE:NSC)
TheStreet Quant Ratings rates Masco Corporation (NYSE:MAS) as a buy. The company’s strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, impressive record of earnings per share growth, compelling growth in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management … Continue reading Stocks to Watch: Masco (NYSE:MAS), Intel (NASDAQ:INTC), Digirad Corporation (NASDAQ:DRAD), Kforce Inc. (NASDAQ:KFRC), Norfolk Southern Corporation (NYSE:NSC)
Investors Are Watching : Banco Bradesco (NYSE:BBD), Qlik Technologies (NASDAQ:QLIK), Albany Molecular Research Inc. (NASDAQ:AMRI), CNB Financial Corp. (NASDAQ:CCNE), Credicorp (NYSE:BAP)
Banco Bradesco S.A. (NYSE:BBD) Brazil’s second-largest private-sector lender, beat second-quarter profit estimates by a large margin on Wednesday after managing to incorporate the impact of higher borrowing costs into earnings. Banco Bradesco S.A. (NYSE:BBD)’s stock on 30 July traded at beginning with a price of $15.69and when day-trade ended the stock finally decreased -1.02% to end at $15.50. Banco Bradesco S.A. (NYSE:BBD)’s showed weekly performance … Continue reading Investors Are Watching : Banco Bradesco (NYSE:BBD), Qlik Technologies (NASDAQ:QLIK), Albany Molecular Research Inc. (NASDAQ:AMRI), CNB Financial Corp. (NASDAQ:CCNE), Credicorp (NYSE:BAP)
Thursday’s Stocks : Altria Group (NYSE:MO), Altera (NASDAQ:ALTR), Artesian Resources Corp. (NASDAQ:ARTNA), BroadVision, Inc. (NASDAQ:BVSN), Pembina Pipeline Corporation (NYSE:PBA)
Altria Group Inc. (NYSE:MO) is the largest tobacco producer in the United States. It owns the industry’s most valuable brand—Marlboro. The company’s stock has performed incredibly well for the first part of 2014—up 9 percent, which isn’t bad for a defensive company. But I think that this outperformance is about to change. Altria Group Inc. (NYSE:MO)’s stock on 30 July traded at beginning with a price … Continue reading Thursday’s Stocks : Altria Group (NYSE:MO), Altera (NASDAQ:ALTR), Artesian Resources Corp. (NASDAQ:ARTNA), BroadVision, Inc. (NASDAQ:BVSN), Pembina Pipeline Corporation (NYSE:PBA)
Top Biotech Stock: Amgen’s AMG 416 Succeeds in Phase III
Amgen Inc(AMGN) shares were up 2.5% following the company’s announcement that AMG 416 (formerly known as velcalcetide) has met the primary as well as secondary endpoints in a randomized, double-blind, placebo-controlled 26-week long phase III study. The study evaluated the efficacy and safety of AMG 416 in 515 chronic kidney disease (CKD) patients receiving hemodialysis and suffering from secondary hyperparathyroidism. Results showed that patients on … Continue reading Top Biotech Stock: Amgen’s AMG 416 Succeeds in Phase III
